with special reference to prevention and control of avian influenza
PLOS ONE | DOI:10.1371/journal.pone.0144057 December 14, 2015
This brief provides key considerations for engaging communities on COVID-19 and tips for how to engage where there are movement restrictions and physical distancing measures in place, particularly in low-resource settings.
Natural disasters often increase morbidity and mortality rates. Taking appropriate measures to maintain environmental health helps to reduce or eliminate the risks of preventable disease and death. Such measures contribute not only to the health of individuals in and near disaster-stricken areas, bu...t they also contribute to decreasing the high costs of providing emergency health services in the aftermath of disaster.
This document is divided into several parts. The first section primarily addresses the effects of natural disasters on environmental health conditions and services. In the second section, environmental health measures are described that should be undertaken in each of three time frames: the predisaster, disaster, and postdisaster periods.
more
Statistical Agency under the President of the Republic of Tajikistan Dushanbe, Republic of Tajikistan
Ministry of Health and Social Protection of Population of the Republic of Tajikistan
Dushanbe, Republic of Tajikistan
The DHS Program ICF
Rockville, Maryland, USA
Common presentations of other significant mental health complaints include: depressed mood, irritability, anxiety, stress, extreme tiredness, unexplained physical complaints. Other significant mental health complaints are frequently seen in non-specialized health settings, but are often treated inap...propriately, with excess investigations and inappropriate medications.
OTH supporting material: Role plays, LIVES intervention, Case scenarios, Alternative relaxation exercises, Multiple choice questions, Video link
more
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar...macies and primary healthcare facilities) and in
hospital settings, as well as for pharmacists working as clinical biologists in medical
analysis laboratories, for example, as clinical biologists, and offer a set of references that
may be consulted for more informationstor
more